Semaglutide Tablets

GLP-1 Receptor Modulator • Appetite Signaling • Metabolic Research

Semaglutide is a long-acting GLP-1 receptor modulator widely studied in metabolic and endocrine research for its impact on appetite regulation, glucose signaling, gastric emptying, and energy homeostasis. Thanks to its enhanced molecular stability and extended activation window, Semaglutide is considered one of the most advanced peptides in GLP-1 research.

Peptide Labs offers Semaglutide in three tablets strengths, allowing researchers to select the ideal format for their experimental design:

✔️ 500 mcg — micro-dosing & receptor activation studies
✔️ 3 mg — standard metabolic research models
✔️ 7 mg — high-strength GLP-1 pathway investigations

Each capsule is produced at 99%+ purity, ensuring maximum accuracy and reproducibility in laboratory studies.

KEY RESEARCH HIGHLIGHTS

1. Appetite Regulation & Satiety Response

Semaglutide interacts with GLP-1 receptors within the hypothalamus, influencing key hunger-signaling pathways. Research shows it may contribute to:

• enhanced satiety

• reduced calorie intake

• slowed gastric emptying

These mechanisms make Semaglutide a powerful molecule for metabolic research involving energy balance and appetite control.

2. Glucose Modulation & Insulin Signaling

Studies indicate Semaglutide supports:

• improved insulin sensitivity

• enhanced β-cell pathway activation

• moderated post-prandial glucose responses

These pathways are central in endocrine and metabolic exploration.

3. Metabolic Rate & Body Composition Research

Due to its GLP-1 activity, Semaglutide may influence:

• lipid oxidation

• metabolic rate elevation

• reductions in visceral fat in research models

• improved nutrient processing pathways

4. Gastric Emptying & Absorption Studies

Semaglutide is frequently used to study:

• slowed gastric emptying

• nutrient absorption rates

• satiety-related feedback mechanisms

This is valuable in digestive and metabolic research settings.

5. Cardiometabolic Stability

Research suggests Semaglutide may support:

• endothelial function

• balanced lipid signaling

• improved vascular metabolic pathways

CAPSULE STRENGTHS

Semaglutide 500 mcg Tablets

Designed for micro-dosing studies, receptor sensitivity trials, and low-intensity GLP-1 activation models.

Strength: 500 mcg per Tablets
Quantity: 25 Tablets

Semaglutide 3 mg Tablets

Ideal for standard metabolic testing, endocrine pathway evaluation, and mid-range GLP-1 research models.

Strength: 3 mg per Tablets
Quantity: 25 Tablets

Semaglutide 7 mg Tablets

A high-concentration GLP-1 research format for extended or advanced metabolic studies requiring increased signaling.

Strength: 7 mg per Tablets
Quantity: 25 Tablets

Form & Stability

All Peptide Labs research capsules are produced with 99%+ purity for consistency and reliability.

Capsule Strengths:

• 500 mcg Semaglutide per Tablets

• 3 mg Semaglutide per Tablets

• 7 mg Semaglutide per Tablets

Quantity:

• 25 Tablets per bottle

Purity:

• 99%+ (HPLC-tested)

Storage:

• Store in a cool, dry place

• Avoid heat, humidity, and direct light

• Keep bottle tightly sealed

Shelf Life:

• Up to 2 years unopened under proper storage

RESEARCH APPLICATIONS OVERVIEW

• GLP-1 receptor activation

• Appetite & satiety pathway research

• Metabolic rate modulation

• Glucose and insulin signaling models

• Gastric emptying studies

• Energy balance & fat utilization

• Cardiometabolic research

Molecular Information

• CAS: 910463-68-2

• Sequence: Synthetic GLP-1 analog (full sequence available upon request)

• Molecular Weight: 4113.6 g/mol

• Form: Tablets